Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

464
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
464
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

857
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
857
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

626
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
626
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

3.2K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.2K
Tonsillitis II: Management01:26

Tonsillitis II: Management

103
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
103

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic engineering of Escherichia coli for acetaldehyde overproduction using pyruvate decarboxylase from Zymomonas mobilis.

Enzyme and microbial technology·2017
Same author

Modified calculation method of relative sensitivity for fluorescence intensity ratio thermometry.

Optics letters·2017
Same author

Residue behavior and risk assessment of imidacloprid applied on greenhouse-cultivated strawberries under different application conditions.

Environmental science and pollution research international·2017
Same author

2-(1-Methylhydrazinyl)pyridine as a reductively removable directing group in a cobalt-catalyzed C(sp<sup>2</sup>)-H bond alkenylation/annulation cascade.

Chemical communications (Cambridge, England)·2017
Same author

Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.

Lung cancer (Amsterdam, Netherlands)·2017
Same author

Efficacy of Biomedical Glue Sling Technique Versus Traditional Technique for Microvascular Decompression for Hemifacial Spasm with Refractory Hypertension.

World neurosurgery·2017

Related Experiment Video

Updated: Jun 7, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.0K

A New Management Strategy for Hemimasticatory Spasm.

Zhongding Zhang1, Datan Lu2, Tingting Ying1

  • 1Department of Neurosurgery, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Yangpu District, Shanghai, People's Republic of China.

Journal of Neurological Surgery. Part A, Central European Neurosurgery
|November 20, 2024
PubMed
Summary

Highly selective trigeminal motor root rhizotomy (HSTR) effectively treats hemimasticatory spasm (HMS), a rare trigeminal nerve disorder. Surgical intervention significantly alleviates symptoms with minimal complications, offering a promising treatment strategy.

More Related Videos

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.0K
Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

1.4K

Related Experiment Videos

Last Updated: Jun 7, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.0K
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

23.0K
Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

1.4K

Area of Science:

  • Neurology
  • Neurosurgery
  • Movement Disorders

Background:

  • Hemimasticatory spasm (HMS) is an uncommon unilateral movement disorder affecting mastication muscles.
  • The underlying mechanisms of HMS remain unclear, necessitating effective treatment development.

Purpose of the Study:

  • To investigate the clinical characteristics of HMS.
  • To evaluate the efficacy of surgical treatment for HMS.

Main Methods:

  • Retrospective analysis of 12 HMS patients.
  • Surgical intervention involved highly selective trigeminal motor root rhizotomy (HSTR), with or without microvascular decompression.

Main Results:

  • Nine patients achieved uneventful recovery with no residual spasms.
  • Two patients experienced complete symptom resolution within 3 months post-surgery.
  • One patient had symptom recurrence 2 years after initial improvement.

Conclusions:

  • HSTR is a safe and effective surgical procedure for managing hemimasticatory spasm.
  • Surgical intervention significantly alleviates HMS symptoms with low complication rates.